MediMix Oncology
  • Home
  • Congresses
    • 2026
      • ESMO GI 2026
      • ASCO 2026
      • ELCC 2026
      • ENETS 2026
      • BSMO 50 YEARS
      • ASCO GU 2026
      • ASCO GI 2026
    • 2025
      • SABCS 2025
      • SIOG 2025
      • ESMO 2025
      • WCLC 2025
      • EADO 2025
  • STiP
  • Webinars
    • ESDO – GI Cancer – ASCO GI 2026
    • ESDO GI Cancer – ESMO 2025
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
    • Respirology
    • Cardiology
    • Rheumatology
    • Neurology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
Breast CancerSan Antonio 2022

The impact of BMI, parity and age of first pregnancy in lobular BC

10 December 2022

Dr Karen Van Baelen, a PhD researcher at the KULeuven, is currently doing a research project on primary invasive lobular breast cancer. At the SABCS 2022, she presented two posters for this population. The first poster showed whether BMI is associated with changes in clinicopathological features and prognosis. In a second poster, she investigated if parity and age at the first full-term pregnancy are associated with the prevalence of ER+ HER2- pure invasive lobular breast cancer in an ER+ HER- breast cancer cohort.

Tags:

poster

Share Article

No Comment! Be the first one.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Website created by MediMix © 2026 - Privacy Policy

  • Home
  • Congresses
    • 2026
      • ESMO GI 2026
      • ASCO 2026
      • ELCC 2026
      • ENETS 2026
      • BSMO 50 YEARS
      • ASCO GU 2026
      • ASCO GI 2026
    • 2025
      • SABCS 2025
      • SIOG 2025
      • ESMO 2025
      • WCLC 2025
      • EADO 2025
  • STiP
  • Webinars
    • ESDO – GI Cancer – ASCO GI 2026
    • ESDO GI Cancer – ESMO 2025
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
    • Respirology
    • Cardiology
    • Rheumatology
    • Neurology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.